Gapping up
In reaction to strong earnings/guidance:
- N/A.
Other news:
- CDW +6.4% (to join S&P 500), TLRD +2.9% (President/CEO and Director each disclosed the purchase of 15K)
- ROAD +2.8% (prices secondary offering of 5 mln shares of its Class A common stock by certain shareholders at $14.25 per share )
- BE +2.7% (after closing more than 20% lower on cautious newsletter report)
- PLUG +1.8% (announces 'five-year plan that will position the company to deliver on an annual basis by 2024 $1 billion of revenue')
- LTRPA +1.2% (ticking higher; President/CEO disclosed the purchase of ~15K shares of Series B Common Stock worth ~$160K)
- KDMN +0.8% (announced that the FDA has approved its generic Trientine Hydrochloride Capsules USP, 250 mg)
Analyst comments:
- TELL +1.4% (initiated with Outperform at Evercore ISI; tgt $14)
- AEO +1.1% (initiated with a Buy at DA Davidson)
- CACI +0.8% (added to Conviction Buy list at Goldman)